Pulse Biosciences
PLSE
48 hedge funds and large institutions have $59.8M invested in Pulse Biosciences in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 9 closing their positions.
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
0.14% less ownership
Funds ownership: 13.88% → 13.74% (-0.14%)
13% less funds holding
Funds holding: 55 → 48 (-7)
31% less capital invested
Capital invested by funds: $86.7M → $59.8M (-$26.8M)
65% less call options, than puts
Call options by funds: $186K | Put options by funds: $536K
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.38M |
| 2 |
Morgan Stanley
New York
|
+$525K |
| 3 |
GAM
Griffin Asset Management
New York
|
+$289K |
| 4 |
Barclays
London,
United Kingdom
|
+$223K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$221K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$892K |
| 2 |
Two Sigma Investments
New York
|
-$455K |
| 3 |
Vontobel Holding
Zurich,
Switzerland
|
-$432K |
| 4 |
Two Sigma Advisers
New York
|
-$319K |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$114K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Vontobel Holding
Zurich,
Switzerland
| – | -$432K | -20,000 | Closed |
|
|
MIM
52
MetLife Investment Management
Whippany,
New Jersey
| – | -$114K | -5,276 | Closed |
|
53
SG Americas Securities
New York
| – | -$102K | -4,717 | Closed |
|
|
MLICM
54
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$86.2K | -3,991 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | -$10.1K | -505 | Closed |
|
|
HFS
56
Horizon Financial Services
Winston Salem,
North Carolina
| – | -$9K | -400 | Closed |
|
|
PA
57
Parallel Advisors
San Francisco,
California
| – | -$5K | -250 | Closed |
|
PLSE Hedge Fund Activity: Q4 2021 in Review
48 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2021, worth a combined $59.8M — down 31% from $86.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PLSE and 3 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 20 added.
The largest buyer was Granahan Investment Management, adding an estimated $1.38M. The largest seller was Vanguard Group, cutting an estimated $892K.
- 48 institutional investors held Pulse Biosciences (PLSE) as of Q4 2021, down from 55 in Q3 2021.
- Funds reported $59.8M of Pulse Biosciences stock for Q4 2021, down 31% quarter-over-quarter.
- 3 funds opened new Pulse Biosciences positions in Q4 2021 and 9 closed out, a net change of -6 holders.
- The largest Pulse Biosciences buyer in Q4 2021 was Granahan Investment Management, an estimated $1.38M added.
- The largest Pulse Biosciences seller in Q4 2021 was Vanguard Group, an estimated $892K sold.
Based on aggregated 13F filings for Q4 2021.